4.4 Article

Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease

Related references

Note: Only part of the references are listed.
Article Peripheral Vascular Disease

Accuracy of Small Dense Low-density Lipoprotein-cholesterol Concentration Estimated via Sampson's Equation in Healthy Subjects and Patients with Diabetes

Tsutomu Hirano et al.

Summary: This study examined the difference between Sampson's equation and direct measurement of sdLDL-C in patients with diabetes. It was found that the calculated sdLDL-C values using Sampson's equation were higher than the direct measurement, and the accuracy of the equation was influenced by diet and medication.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2023)

Review Cardiac & Cardiovascular Systems

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies

Xiao Jin et al.

Summary: This article summarizes the possible mechanisms of sdLDL-C in atherosclerosis (AS). Research has found that sdLDL-C increases the risk of AS by regulating gene networks, monocytes, and enzymes. Furthermore, the article reviews the effects of sdLDL-C on endothelial function, lipid metabolism, and inflammation, as well as discusses intervention methods.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Biochemistry & Molecular Biology

Small dense low-density lipoprotein particles: clinically relevant?

Ronald M. Krauss

Summary: Levels of small, dense low-density lipoprotein (sdLDL) particles have been associated with risk of atherosclerotic cardiovascular disease (ASCVD). There is sufficient evidence to suggest measuring sdLDL for assessing and managing cardiovascular disease risk.

CURRENT OPINION IN LIPIDOLOGY (2022)

Review Biochemistry & Molecular Biology

Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels

Harold Superko et al.

Summary: Despite statin use and LDL-C reduction, residual cardiovascular disease event risk remains. Abnormal lipoprotein size and density distribution, known as lipoprotein heterogeneity, contributes to this residual risk. Recent clinical trial evidence reinforces the importance of LDL heterogeneity measurement and its impact on CHD risk prediction and outcomes.

BIOMEDICINES (2022)

Article Peripheral Vascular Disease

The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk

Mayu Higashioka et al.

Summary: The study investigated the association between serum small dense low-density lipoprotein (sdLDL) cholesterol level and development of coronary heart disease (CHD) in high cardiovascular risk subjects. Elevated sdLDL cholesterol was found to be significantly associated with increased risk of CHD, especially in patients with diabetes, CVD-related comorbidities, and high-risk category.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)

Article Medical Laboratory Technology

A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test

Maureen Sampson et al.

Summary: The study introduces two new equations for calculating large buoyant LDL-C and small dense LDL-C based on standard lipid panel results. The equations were found to potentially improve ASCVD risk stratification.

CLINICAL CHEMISTRY (2021)

Article Peripheral Vascular Disease

Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community

Mayu Higashioka et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2020)

Article Endocrinology & Metabolism

Japanese Clinical Practice Guideline for Diabetes 2019

Eiichi Araki et al.

JOURNAL OF DIABETES INVESTIGATION (2020)

Article Peripheral Vascular Disease

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Satoshi Umemura et al.

HYPERTENSION RESEARCH (2019)

Review Peripheral Vascular Disease

Pathophysiology of Diabetic Dyslipidemia

Tsutomu Hirano

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)

Article Biochemistry & Molecular Biology

Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels

Toshiyuki Hayashi et al.

LIPIDS IN HEALTH AND DISEASE (2017)

Article Cardiac & Cardiovascular Systems

Arterial Thickness and Immunometabolism: The Mediating role of Chronic Exercise

B. M. M. Antunes et al.

CURRENT CARDIOLOGY REVIEWS (2016)

Article Medical Laboratory Technology

Development of a Homogeneous Assay for Measurement of Small Dense LDL Cholesterol

Yasuki Ito et al.

CLINICAL CHEMISTRY (2011)

Article Urology & Nephrology

Revised Equations for Estimated GFR From Serum Creatinine in Japan

Seiichi Matsuo et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2009)

Review Peripheral Vascular Disease

Measurement of small dense low-density lipoprotein particles

T Hirano et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2005)

Article Public, Environmental & Occupational Health

Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples

EF Schisterman et al.

EPIDEMIOLOGY (2005)

Article Cardiac & Cardiovascular Systems

New criteria for 'obesity disease' in Japan

Y Matsuzawa et al.

CIRCULATION JOURNAL (2002)

Review Biochemistry & Molecular Biology

Metabolic origins and clinical significance of LDL heterogeneity

KK Berneis et al.

JOURNAL OF LIPID RESEARCH (2002)